Afimoxifene
Term · Oncology and biomedicine · MLC-T-ONC-009724
A tamoxifen metabolite with both estrogenic and anti-estrogenic effects. Afimoxifene has a higher affinity for the estrogen receptor than tamoxifen, and functions as an antagonist in breast cancer cells.
| Identifier | MLC-T-ONC-009724 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | 4-OHT |
| Synonyms | 4-hydroxytamoxifen; 4-hydroxy-tamoxifen |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009724",
"term": "Afimoxifene",
"field": "Oncology and biomedicine",
"definition": "A tamoxifen metabolite with both estrogenic and anti-estrogenic effects. Afimoxifene has a higher affinity for the estrogen receptor than tamoxifen, and functions as an antagonist in breast cancer cells.",
"abbreviation": "4-OHT",
"synonyms": [
"4-hydroxytamoxifen",
"4-hydroxy-tamoxifen"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/afimoxifene/"
}
Record 523 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.